Actively hiring
Oncology Therapeutics
Prescription Drugs
Follow
Overview
Salaries
Products
People
Growth
Offices
Financials
Funding and backers
Team
51-200
employees, estimated range
Backers
1
Nextech Invest
Momentum
0/100
no fresh signals
Tractionpublic signals, read monthly
Web presence
top 5%
of 133.2M domains by links, Common Crawl
Registers and programsofficial lists and records that name the company
| Legal entity | ITM Isotope Technologies Munich SE | its site |
Backed byfrom the funds' portfolios and accelerator catalogs
Similar startupsby what they do, their industry and backers

Mapping Biology to Precise Medicines The best therapeutics are built around the best targets. By analyzing massive datasets from individual…

Novel ADC Payloads for Cancer Hexagon Bio is developing novel payload mechanisms for antibody-drug conjugates (ADCs) to overcome resistance…

Committed to developing high-impact and differentiated therapies, with a focus on building a robust autoimmune disease and cancer pipeline…

Cloverleaf Bio | Developing a new class of RNA therapeutics to revolutionize cancer therapy.

Targeting the Tumor Ecosystem to address cancer drug resistance and improve patients’ lives.

Yemaachi is creating the world's most diverse cancer bio-database to develop the next generation of cancer drugs that are effective in…
Offices
Where the company hires and what each office is for
Cities
2
Hiring now
0
Countries
1
Loading the map
Headquarters
Builds here
Office with open vacancies
No open vacancies right now Tap a pin for the office
Garching bei München
Germany
HQ
IAZ Production Facility
Munich
Germany
Registered seat
Lichtenbergstraße 1, Munich, 85748, DE

Nextech Invest